Healthcare

Middle East accelerates AI applications in healthcare

A regional analysis highlighted Saudi Arabia, Qatar, and the UAE as major Middle Eastern markets for AI diagnostics, virtual hospitals, precision medicine, and genomic healthcare.

A BioSpectrum Asia analysis described the Middle East as an active market for digital health applications including virtual hospitals and AI-powered diagnostics. It highlighted Saudi Arabia’s Vision 2030 ambitions, the Saudi Data & AI Authority, and national efforts to develop AI and data capabilities. The article also described Qatar’s focus on precision medicine, telemedicine, and genomic research under Qatar National Vision 2030. According to the report, AI diagnostic tools are being used to support conditions including cancer and cardiovascular disease. The UAE was presented as another major market, with national strategies placing healthcare at the center of digital innovation. The article linked these developments to wider investments in data centers, digital infrastructure, and technology partnerships. For healthcare providers, the trend indicates that AI is being developed as part of broader modernization programs rather than as isolated clinical software. Virtual care, diagnostics, genomics, and data infrastructure are converging to create new delivery models. The significance for the industry is the scale of regional ambition: governments are combining policy, capital, infrastructure, and health-system reform to accelerate practical AI adoption.

Original source: BioSpectrum Asia

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI